Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628534 · ClinicalTrials.gov registry record · NA
SERF VT Ablation Early Feasibility Study (EFS)
A NA study, sponsored by Thermedical.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03628534 is a NA study that has completed, run by Thermedical. The registered enrollment target is 16 participants.
The verdict
NCT03628534, a NA study, has completed, sponsored by Thermedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is an early feasibility, non-randomized, open-label, single group, interventional study to be conducted in up to 20 US subjects to evaluate the technical feasibility of the Durablate Catheter and Thermedical Ablation System to eliminate or control sustained, monomorphic ventricular tachycardia (VT) in patients with VT refractory to drug and conventional catheter ablation with acceptable procedural safety.
Interventions
- DEVICE Saline Enhanced Radiofrequency (SERF) ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03628534
The ClinicalTrials.gov registry entry for NCT03628534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thermedical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Saline Enhanced Radiofrequency (SERF) ablation is the first listed.
NCT03628534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03628534 about?
NCT03628534 is a clinical study titled "SERF VT Ablation Early Feasibility Study (EFS)". This is an early feasibility, non-randomized, open-label, single group, interventional study to be conducted in up to 20 US subjects to evaluate the technical feasibility of the Durablate Catheter and Thermedical Ablation System to eliminate or control sustained, monomorphic ventricular tachycardia ...
What is the current status of trial NCT03628534?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-11-01. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT03628534?
The interventions under investigation include: Saline Enhanced Radiofrequency (SERF) ablation (DEVICE).
Who is sponsoring clinical trial NCT03628534?
This trial is sponsored by Thermedical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.